D
메타케어
118000KOSPI기계장비 및 관련 물품 도매업38.0 / 100
Reference Date: 2026-04-13
Financial Score10.5 / 40
News Sentiment12.5 / 25
Momentum5.0 / 20
Disclosure10.0 / 15
AI Analysis: PBR is significantly undervalued vs. peers but the high debt ratio poses financial risk. Slightly down 4.7% over the past month, with no recent news.
Company InformationBased on 2025 Annual Report
Business Overview
MetaCare operates across four business segments: Pharmaceuticals, Medical, Investment, and Real Estate Development, with the Pharmaceuticals segment contributing 77.2% of total revenue. The company has expanded its market presence through acquisitions, such as J&N Pharm and H Bio&Co, and achieved 2.8% revenue share from Real Estate Development in 2024.
Number of Employees
32people
Average Salary
65.7M KRW
Score Calculation Basis
Detailed Financial Score
PER
74.33Industry Average 10.900.0Point
6.8x industry avg (risky)
PBR
0.32Industry Average 0.777.0Point
Half of industry avg (excellent)
ROE
-0.18Industry Average 3.030.0Point
Well below industry avg
Debt Ratio
20.74Industry Average 6.160.0Point
3.4x industry avg (risky)
Trend 2023~20253.5 / 10 points
Revenue Growth Rate
0.5 / 3
Avg ▼0.7% (2-year basis)
Operating Profit Growth Rate
3.0 / 3
Avg ▲52.5% (2-year basis)
ROE Trend
0.0 / 4
Avg ROE -4.3% (improving, 3yr)
Detailed News Sentiment
0 totalPositive 0Neutral 0Negative 0
Detailed Momentum
52-week position1.0Point
Near 52w low (0%, downtrend)
Current 223Won52-week high 36152-week low 223
1-month return2.0Point
1m -4.70% (slight drop)
Volume trend2.0Point
Volume decreasing
Detailed Disclosure
4 totalPositive 0Neutral 4Negative 0
- Neutral정기주주총회결과2026-03-25
- Neutral사업보고서 (2025.12)2026-03-17
- Neutral[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변경2026-03-16
- Neutral감사보고서제출2026-03-16